Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Cash from Operations (2019 - 2025)

Historic Cash from Operations for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $108.7 million.

  • Harmony Biosciences Holdings' Cash from Operations rose 5423.04% to $108.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $297.6 million, marking a year-over-year increase of 3471.15%. This contributed to the annual value of $219.8 million for FY2024, which is 19.78% up from last year.
  • According to the latest figures from Q3 2025, Harmony Biosciences Holdings' Cash from Operations is $108.7 million, which was up 5423.04% from $79.3 million recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Cash from Operations ranged from a high of $108.7 million in Q3 2025 and a low of $12.5 million during Q1 2021
  • Moreover, its 5-year median value for Cash from Operations was $37.5 million (2021), whereas its average is $47.6 million.
  • As far as peak fluctuations go, Harmony Biosciences Holdings' Cash from Operations skyrocketed by 27396.52% in 2021, and later tumbled by 2892.12% in 2022.
  • Harmony Biosciences Holdings' Cash from Operations (Quarter) stood at $37.5 million in 2021, then dropped by 28.92% to $26.7 million in 2022, then soared by 187.37% to $76.7 million in 2023, then decreased by 1.44% to $75.6 million in 2024, then skyrocketed by 43.9% to $108.7 million in 2025.
  • Its Cash from Operations stands at $108.7 million for Q3 2025, versus $79.3 million for Q2 2025 and $34.0 million for Q1 2025.